These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 18023656
1. Aprotinin is safe in pediatric patients undergoing cardiac surgery. Backer CL, Kelle AM, Stewart RD, Suresh SC, Ali FN, Cohn RA, Seshadri R, Mavroudis C. J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1421-6; discussion 1426-8. PubMed ID: 18023656 [Abstract] [Full Text] [Related]
2. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass. Manrique A, Jooste EH, Kuch BA, Lichtenstein SE, Morell V, Munoz R, Ellis D, Davis PJ. Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694 [Abstract] [Full Text] [Related]
3. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Kincaid EH, Ashburn DA, Hoyle JR, Reichert MG, Hammon JW, Kon ND. Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876 [Abstract] [Full Text] [Related]
4. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis. Guzzetta NA, Evans FM, Rosenberg ES, Fazlollah TM, Baker MJ, Wilson EC, Kaiser AM, Tosone SR, Miller BE. Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271 [Abstract] [Full Text] [Related]
5. Aprotinin in cardiac surgery patients: is the risk worth the benefit? Stamou SC, Reames MK, Skipper E, Stiegel RM, Nussbaum M, Geller R, Robicsek F, Lobdell KW. Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574 [Abstract] [Full Text] [Related]
6. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid. Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A. J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324 [Abstract] [Full Text] [Related]
7. Aprotinin and renal dysfunction after pediatric cardiac surgery. Székely A, Sápi E, Breuer T, Kertai MD, Bodor G, Vargha P, Szatmári A. Paediatr Anaesth; 2008 Feb; 18(2):151-9. PubMed ID: 18184247 [Abstract] [Full Text] [Related]
8. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT. Am J Nephrol; 2008 Feb; 28(4):576-82. PubMed ID: 18264006 [Abstract] [Full Text] [Related]
9. Retrospective cohort analysis of a single dose of aprotinin use in children undergoing cardiac surgery: a single-center experience. Fan Y, Lin R, Yang L, Ye L, Yu J, Shu Q. Paediatr Anaesth; 2013 Mar; 23(3):242-9. PubMed ID: 23189963 [Abstract] [Full Text] [Related]
10. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China. Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Li L, Hu S. J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368 [Abstract] [Full Text] [Related]
11. Impact of aprotinin on adverse clinical outcomes and mortality up to 12 years in a registry of 3,337 patients. Olenchock SA, Lee PH, Yehoshua T, Murphy SA, Symes J, Tolis G. Ann Thorac Surg; 2008 Aug; 86(2):560-6; discussion 566-7. PubMed ID: 18640334 [Abstract] [Full Text] [Related]
12. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion. Kristeller JL, Stahl RF, Roslund BP, Roke-Thomas M. Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204 [Abstract] [Full Text] [Related]
13. Aprotinin may decrease blood loss in complex adult spinal deformity surgery, but it may also increase the risk of acute renal failure. Okubadejo GO, Bridwell KH, Lenke LG, Buchowski JM, Fang DD, Baldus CR, Nielsen CH, Lee CC. Spine (Phila Pa 1976); 2007 Sep 15; 32(20):2265-71. PubMed ID: 17873821 [Abstract] [Full Text] [Related]
14. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin. Dietrich W, Busley R, Boulesteix AL. Anesthesiology; 2008 Feb 15; 108(2):189-98. PubMed ID: 18212563 [Abstract] [Full Text] [Related]
15. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, Djaiani G, Ivanov J, Karski J, David TE. J Thorac Cardiovasc Surg; 2005 Feb 15; 129(2):391-400. PubMed ID: 15678051 [Abstract] [Full Text] [Related]
16. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R. Anesth Analg; 2008 Nov 15; 107(5):1469-78. PubMed ID: 18931201 [Abstract] [Full Text] [Related]
17. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study. Ngaage DL, Cale AR, Cowen ME, Griffin S, Guvendik L. Ann Thorac Surg; 2008 Oct 15; 86(4):1195-202. PubMed ID: 18805159 [Abstract] [Full Text] [Related]
18. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS. Anesth Analg; 2010 Jan 01; 110(1):21-9. PubMed ID: 19910626 [Abstract] [Full Text] [Related]
19. The risk associated with aprotinin in cardiac surgery. Mangano DT, Tudor IC, Dietzel C, Multicenter Study of Perioperative Ischemia Research Group, Ischemia Research and Education Foundation. N Engl J Med; 2006 Jan 26; 354(4):353-65. PubMed ID: 16436767 [Abstract] [Full Text] [Related]
20. A comparison of the effect of aprotinin and ε-aminocaproic acid on renal function in children undergoing cardiac surgery. Leyvi G, Nelson O, Yedlin A, Pasamba M, Belamarich PF, Nair S, Cohen HW. J Cardiothorac Vasc Anesth; 2011 Jun 26; 25(3):402-6. PubMed ID: 21419653 [Abstract] [Full Text] [Related] Page: [Next] [New Search]